Montana’s Drug Experiment: A Warning for All Tech Adoption

According to a report from MIT Technology Review, Montana has passed a new law that lets biotech companies sell experimental drugs after only limited testing—sometimes on as few as ten people—for a $12,500 fee. This creates a fast track for treatments with very little safety data. The idea is to give desperate patients more options, but it also opens the door to serious risks.

This story matters because it shows what happens when the urge to innovate overruns the need for caution. The same tension between speed and safety is playing out right now in the world of artificial intelligence. Many AI tools are released to the public before their flaws are fully understood, and businesses feel pressure to adopt them immediately or risk falling behind.

The Real Cost of Jumping on Unproven AI Tools

In the rush to gain a competitive edge, some companies treat AI like Montana treats experimental drugs—they skip the careful testing and hope for the best. But when an AI system makes a mistake, the consequences can be expensive: bad customer service, wrong data analysis, or even compliance failures. Unlike Montana’s law, there is no waiver for “informed consent” when a chatbot gives a wrong answer to a client.

Artificial intelligence is powerful, but it is not magic. Models can hallucinate facts, amplify bias, or fail in unpredictable ways. For businesses, especially small and mid-sized ones without deep pockets, a bad AI rollout can cost time, money, and reputation. The Montana story reminds us that “fast” does not automatically mean “good.”

What This Means for Australian SMBs

Australian small and mid-sized businesses are being flooded with offers of AI automation tools. From customer support bots to inventory management systems, the promises are big. But the Montana example shows that early adoption of unvetted technology carries real danger. SMBs don’t have the same margin for error as large corporations—one wrong decision can hurt cash flow or customer trust.

The Australian market also has its own regulatory landscape, particularly around data privacy and consumer law. Jumping onto an AI platform that hasn’t been tested under local conditions could lead to legal headaches. The smart move is to learn from Montana’s experiment: demand proof before you sign up.

What You Can Do Now

  • Test before you invest. Run a small pilot project with any new AI tool. Check for accuracy, bias, and how it handles your specific business data.
  • Ask vendors for evidence. Request case studies, third-party audits, or real-world results. Don’t rely on marketing hype alone.
  • Understand the limits. Read the fine print on liability. If the AI makes a mistake, who pays? Make sure your contract answers that.
  • Stay informed on local rules. Keep an eye on Australian regulations for AI and data use. What works in another country might not be legal here.
  • Consult a trusted partner. Work with an IT services provider that knows both technology and the local business environment. A second opinion can save you from a costly error.

At MS&VG, we help Australian SMBs navigate the fast-changing world of business AI—without the trial-and-error approach Montana is now testing. Our team can guide you through safe, practical adoption that fits your real needs.